Adjuvant systemic therapy in older women with breast cancer

QR Code

Adjuvant systemic therapy in older women with breast cancer

Julieta Leone,1 Bernardo Amadeo Leone,1 José Pablo Leone2 1Department of Medical Oncology, Grupo Oncológico Cooperativo del Sur (GOCS), Neuquén, Argentina; 2Department of Internal Medicine, Division of Hematology-Oncology and Blood & Marrow Transplantation, U...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Leone J, Leone BA, Leone JP
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2016
Sujets:	Breast Cancer Adjuvant Therapy Chemotherapy Endocrine Therapy Elderly. Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/8a9ad08e60214e8889f202e54ed37e10
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Are another 5 years of adjuvant aromatase inhibitor therapy needed?
par: Mo QG, et autres
Publié: (2016)

Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study
par: Wako Z, et autres
Publié: (2021)

Time to Adjuvant Chemotherapy and Its Predictors Among Women with Breast Cancer at the University of Gondar Compressive Specialized Hospital: A Retrospective Follow-Up Study
par: Zeleke Alem A, et autres
Publié: (2020)

Resistance and Overcoming Resistance in Breast Cancer
par: Luque-Bolivar A, et autres
Publié: (2020)

Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
par: Butani D, et autres
Publié: (2021)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
par: Hyder T, et autres
Publié: (2021)

The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer
par: Yi-Kun Kang, et autres
Publié: (2021)

Association of Endocrine Therapy and Dementia in Women with Breast Cancer
par: Thompson MR, et autres
Publié: (2021)

Prospects for the development of adjuvant therapy for non-small cell lung cancer
par: K. K. Laktionov, et autres
Publié: (2020)

Adjuvant targeted therapy for non-small cell lung cancer
par: Konstantin K. Laktionov, et autres
Publié: (2020)

Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer
par: Venturelli M, et autres
Publié: (2018)

A Retrospective Analysis of the Effect of Irinotecan-Based Regimens in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
par: Jiaojiao Suo, et autres
Publié: (2021)

Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
par: Inna P. Ganshina, et autres
Publié: (2021)

Hormone Therapy and Factors Affecting Fertility of Women Under 50-Year-Old with Breast Cancer
par: Moradinazar M, et autres
Publié: (2019)

Comparison Of Accelerated Partial Breast Radiation Therapy And External Beam Radiation Therapy By Treatment Planning Indices
par: Hejazi P, et autres
Publié: (2019)

A Prognostic Nomogram for T3N0 Rectal Cancer After Total Mesorectal Excision to Help Select Patients for Adjuvant Therapy
par: Chao Zhang, et autres
Publié: (2021)

Statins and risk of breast cancer recurrence
par: Sakellakis M, et autres
Publié: (2016)

TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer
par: Isabel Grote, et autres
Publié: (2021)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
par: Fleisher B, et autres
Publié: (2016)

Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP)
par: Matthias Balk, et autres
Publié: (2021)

Antiangiogenic therapy for breast cancer with triple negative phenotype
par: Inna P. Ganshina, et autres
Publié: (2021)

An Insight into the Role of Bee Venom and Melittin Against Tumor Cells: A Review of Breast Cancer therapy
par: Roha Tariq, et autres
Publié: (2021)

Genetic Influences in Breast Cancer Drug Resistance
par: Daniyal A, et autres
Publié: (2021)

Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity
par: Sambi M, et autres
Publié: (2017)

Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?
par: Roberta Maltoni, et autres
Publié: (2022)

Integrative Radiogenomics Approach for Risk Assessment of Postoperative and Adjuvant Chemotherapy Benefits for Gastric Cancer Patients
par: Yin Jin, et autres
Publié: (2021)

Efficacy and Safety of Central Memory T Cells Combined With Adjuvant Therapy to Prevent Recurrence of Hepatocellular Carcinoma With Microvascular Invasion: A Pilot Study
par: Jianqiang Cai, et autres
Publié: (2021)

Does the Presence of Cytokeratin Positive Individual Tumor Cells (N0(I+)) in Sentinel Lymph Nodes Affect Clinical Outcomes in Breast Cancer Patients Treated with Accelerated Partial Breast Irradiation
par: Smith J, et autres
Publié: (2021)

A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model
par: Soliman H, et autres
Publié: (2015)

Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomy
par: Se Ik Kim, et autres
Publié: (2021)

Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer
par: Savioli F, et autres
Publié: (2021)

Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review
par: Rokuro Morii, et autres
Publié: (2021)

A Systematic Review and Meta-Analysis on the Number of Adjuvant Temozolomide Cycles in Newly Diagnosed Glioblastoma
par: Fahimeh Attarian, et autres
Publié: (2021)

Awareness and current knowledge of breast cancer
par: Akram,Muhammad, et autres
Publié: (2017)

Breast cancer prevention in older women: an algorithm to choose an optimal preventive agent
par: Ozdemir BZ, et autres
Publié: (2019)

Positive margins (R1) risk factors in breast cancer conservative surgery
par: Lombardi A, et autres
Publié: (2019)

Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
par: Yizhao Xie, et autres
Publié: (2021)

A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma
par: Kunnuru SKR, et autres
Publié: (2020)

Variation in the management of elderly patients in two neighboring breast units is due to preferences and attitudes of health professionals
par: Morrow ES, et autres
Publié: (2019)

Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience
par: Irina V. Kolyadina, et autres
Publié: (2020)